Trulicity (dulaglutide) Letter of Medical Necessity
Trulicity (dulaglutide) is often a step therapy alternative when Ozempic is preferred. LMNs should address prior treatment, A1c targets, and CV risk indications when applicable. For payer-by-payer GLP-1 criteria, see our GLP-1 Prior Authorization Guide.
FDA-Approved Indications
- ● type 2 diabetes mellitus
- ● CV risk reduction in T2DM with established CVD or risk factors
Why Trulicity Prior Authorization Gets Denied
The most common denial reasons across major payers:
- 1. Metformin trial not documented
- 2. A1c criterion not met
- 3. Preferred GLP-1 (Ozempic) not tried
- 4. Quantity limit
What to Include in a Trulicity Letter of Medical Necessity
Document T2DM diagnosis, current and goal A1c, prior antihyperglycemic agents, contraindications to alternative GLP-1s, and REWIND CV risk data for patients with established CVD.
Key clinical evidence to cite:
- ✓ AWARD 1-11 trials
- ✓ REWIND CV outcomes trial
- ✓ AWARD-PEDS for pediatric T2DM
Relevant guidelines:
- 📖 ADA 2024 Standards of Care
- 📖 AACE 2022 Algorithm
- 📖 ESC 2023 CV Risk Guidelines
Trulicity Prior Authorization Criteria
Standard criteria across major US payers for Trulicity. Specific criteria vary by plan — RxCheckUp tailors each LMN to your patient's exact payer policy.
Typical step therapy requirements:
- → Metformin trial not documented
Required documentation:
- ✓ ICD-10 diagnosis code with specificity
- ✓ Prior therapy history with dates, doses, and discontinuation reasons
- ✓ Specialist evaluation (where applicable)
- ✓ Baseline disease activity or biomarker results
- ✓ Clinical rationale citing FDA labeling or guidelines
Approval details:
Initial approval: typically 6 months. Renewal: 12 months with documented clinical response.
Payers Covering Trulicity
RxCheckUp tailors each LMN to the specific payer's medical policy and step therapy requirements:
Trulicity Prior Authorization FAQ
Why was my Trulicity prior authorization denied?
The most common denial reasons for Trulicity are: Metformin trial not documented; A1c criterion not met; Preferred GLP-1 (Ozempic) not tried; Quantity limit.
What should a Trulicity Letter of Medical Necessity include?
Document T2DM diagnosis, current and goal A1c, prior antihyperglycemic agents, contraindications to alternative GLP-1s, and REWIND CV risk data for patients with established CVD.
Which payers cover Trulicity?
Trulicity is covered by major US payers including UnitedHealthcare, Aetna, Cigna, CVS Caremark, Express Scripts, though formulary tier and prior authorization criteria vary.